Table 3 Five-year conditional relative survival at diagnosis of multiple myeloma and after surviving 1, 3, and 5 years
Age at diagnosis | Number of patients observed in period 2015–2019 | Five-year conditional relative survival (95% CI) | ||||||
|---|---|---|---|---|---|---|---|---|
At diagnosis | After surviving 1 year | After surviving 3 years | After surviving 5 years | At diagnosis | After surviving 1 year | After surviving 3 years | After surviving 5 years | |
Men | ||||||||
Total (15–79 years) | 4706 | 3777 | 2441 | 1305 | 60.9 (58.8–63.0) | 64.9 (62.5–67.3) | 65.5 (62.3–68.7) | 68.3 (61.9–74.6) |
15–69 yrs | 2823 | 2344 | 1587 | 878 | 67.2 (64.6–69.7) | 69.3 (66.5–72.0) | 70.0 (66.5–73.5) | 78.2 (72.4–83.9) |
70–79 yrs | 1883 | 1433 | 854 | 427 | 51.9 (48.4–55.4) | 57.7 (53.5–61.9) | 55.9 (49.4–62.3) | 39.7 (23.3–56.2) |
Women | ||||||||
Total (15–79 years) | 3492 | 2853 | 1863 | 1052 | 60.2 (57.9–62.5) | 64.2 (61.7–66.8) | 65.4 (62.0–68.8) | 65.5 (58.3–72.8) |
15–69 yrs | 1972 | 1675 | 1111 | 679 | 71.1 (68.3–74.0) | 71.9 (68.9–75.0) | 71.3 (67.3–75.3) | 67.4 (58.5–76.4) |
70–79 yrs | 1520 | 1178 | 752 | 373 | 47.3 (43.7–50.8) | 54.0 (49.8–58.2) | 56.4 (50.4–62.4) | 61.5 (49.0–73.9) |
Both | ||||||||
Total (15–79 years) | 8198 | 6630 | 4304 | 2357 | 60.6 (59.1–62.2) | 64.6 (62.9–66.3) | 65.5 (63.1–67.8) | 67.0 (62.3–71.8) |
15–69 yrs | 4795 | 4019 | 2698 | 1557 | 68.8 (66.9–70.7) | 70.4 (68.3–72.4) | 70.5 (67.9–73.1) | 73.7 (68.7–78.7) |
70–79 yrs | 3403 | 2611 | 1606 | 800 | 49.7 (47.2–52.2) | 55.9 (53.0–58.9) | 56.2 (51.8–60.6) | 51.7 (41.4–62.0) |